Incerti Carlo 4
4 · Dyne Therapeutics, Inc. · Filed May 25, 2023
Insider Transaction Report
Form 4
Incerti Carlo
Director
Transactions
- Award
Stock Option (right to buy)
2023-05-24+24,900→ 24,900 totalExercise: $13.49Exp: 2033-05-23→ Common Stock (24,900 underlying)
Footnotes (1)
- [F1]This option was granted on May 24, 2023. The shares underlying the option are scheduled to vest in full on the earlier of (i) May 24, 2024 or (ii) the date of the Issuer's 2024 Annual Meeting of Stockholders.